세계의 나노항체 시장 보고서(2025년)

Nano antibodies, also known as single-domain antibodies or nanobodies, are small antibody fragments derived from the unique heavy-chain antibodies found in camelids. They maintain the full antigen-binding capability of conventional antibodies but offer greater stability, are easier to produce, and can bind to hidden or hard-to-access epitopes.

The primary products of nano antibodies include single-domain antibodies, heavy-chain antibodies, recombinant nano antibodies, conjugated nano antibodies, and bispecific and multispecific nano antibodies. Single-domain antibodies are small, stable antibody fragments derived from heavy-chain-only antibodies that retain full antigen-binding capacity and are used for therapeutic, diagnostic, and research purposes. They are developed using various technologies, such as phage display technology, recombinant deoxyribonucleic acid (DNA) technology, and molecular cloning, and originate from sources such as animal-derived, recombinant, and plant-derived systems. These antibodies are applied across a wide range of uses, including in vitro disease detection, non-invasive in vivo diagnosis, tumor-targeted therapy, nervous system diseases, circulatory diseases, infectious diseases, and more, and serve end users such as pharmaceutical companies, biotechnology firms, academic and research institutions, and hospitals and diagnostic laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The nano antibodies market research report is one of a series of new reports from The Business Research Company that provides nano antibodies market statistics, including nano antibodies industry global market size, regional shares, competitors with a nano antibodies market share, detailed nano antibodies market segments, market trends and opportunities, and any further data you may need to thrive in the nano antibodies industry. This nano antibodies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nano antibodies market size has grown rapidly in recent years. It will grow from $1.55 billion in 2024 to $1.80 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period resulted from the increasing prevalence of chronic and infectious diseases, growing adoption of nanobody-based diagnostic tools, rising research funding in biotechnology and life sciences, expanding use of nanobodies in cancer immunotherapy research, and greater awareness of the advantages of nanoantibodies.

The nano antibodies market size is expected to see rapid growth in the next few years. It will grow to $3.27 billion in 2029 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period will be driven by rising demand for precision and personalized medicine, a growing focus on targeted drug delivery systems, an increasing number of clinical trials for nanobody-based therapies, expanding adoption of nanobody-based imaging agents, and growing commercialization of nanoantibody products. Major trends in the forecast period include the development of novel therapeutic applications of nano antibodies, integration of nano antibodies with nanoparticle drug delivery systems, innovations in multiplexed nano antibody screening technologies, incorporation of biosensor technologies for rapid antibody detection, and the integration of nano antibodies into point-of-care diagnostic devices.

The increasing demand for personalized medicines is expected to drive the growth of the nano antibodies market going forward. Personalized medicines are treatments tailored to an individual's genetic makeup, lifestyle, and environment, ensuring the most effective therapy for each patient. The rising prevalence of chronic and rare diseases is fueling this demand, as these conditions often require targeted, patient-specific therapeutic approaches. Nano antibodies support personalized medicine by providing highly specific, customizable, and targeted solutions aligned with individual patient profiles and disease mechanisms. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six approvals in 2022. Therefore, the growing demand for personalized medicines is driving the expansion of the nano antibodies market.

Companies in the nano antibodies market are focusing on developing advanced therapeutics, including fully multispecific nanobodies, to enhance disease targeting and treatment efficacy. Fully multispecific therapeutics are biologics capable of simultaneously binding to two or more targets, enabling more precise and effective interventions for complex diseases. For example, in February 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a China-based biopharmaceutical company, launched the Nano 100 Project to develop fully human nanobody therapeutics against over 100 targets. Using Biocytogen's proprietary RenNan mouse platform, the initiative generates fully human nanobodies without requiring humanization. By combining high-throughput in vitro and in vivo screening technologies, the project aims to accelerate target coverage and nanobody drug discovery. These nanobodies demonstrate strong tissue penetration, stability, and engineering flexibility, making them suitable for modalities such as cell therapies, bispecific antibodies, antibody-drug conjugates (ADCs), and radionuclide antibody conjugates. Ultimately, the Nano 100 Project streamlines the development of novel therapeutics for cancer, immune disorders, and neurological diseases.

In September 2024, Valerion Therapeutics LLC, a France-based biotechnology company, acquired Emglev Therapeutics for an undisclosed amount. This acquisition aimed to enhance Valerion's technological capabilities in antibody therapeutics and accelerate its expansion into next-generation immunotherapies. Emglev Therapeutics specializes in single-domain antibodies (sdAbs), also known as nanobodies, further strengthening Valerion's pipeline in advanced antibody-based therapeutics.

Major companies operating in the nano antibodies market are Sanofi S.A., AstraZeneca plc, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Innovent Biologics Inc., GenScript Biotech Corporation, Biocytogen Pharmaceuticals Co. Ltd., Beroni Group Limited., Cusabio Technology LLC, Harbour BioMed Co. Ltd., MoonLake Immunotherapeutics Co. Ltd., Alphamab Oncology Co. Ltd., Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Promab Biotechnologies Inc., ExeVir Bio N.V., Isogenica Ltd., Allele Biotechnology And Pharmaceuticals Inc., Gulliver Biomed Inc., Capralogics Inc.

North America was the largest region in the nano antibodies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nano antibodies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nano antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nano antibodies market consists of sales of nano antibody constructs, diagnostic reagents, therapeutic formulations, assay kits, and research-grade antibody products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nano Antibodies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nano antibodies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nano antibodies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nano antibodies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Single-Domain Antibodies; Heavy-Chain Antibodies; Recombinant Nano Antibodies; Conjugated Nano Antibodies; Bispecific And Multispecific Nano Antibodies
• 2) By Technology: Phage Display Technology; Recombinant Deoxyribonucleic Acid (DNA) Technology; Molecular Cloning
• 3) By Source: Animal-Derived; Recombinant; Plant-Derived
• 4) By Application: Disease Detection In Vitro; Non-Invasive Diagnosis In Vivo; Tumor Targeted Therapy; Nervous System Disease; Circulatory Disease; Infectious Disease; Other Applications
• 5) By End-User: Pharmaceutical Companies; Biotechnology Firms; Academic And Research Institutions; Hospitals And Diagnostic Laboratories
• Subsegments:
• 1) By Single-Domain Antibodies: Human Single-Domain Antibodies; Camelid Single-Domain Antibodies; Synthetic Single-Domain Antibodies; Shark-Derived Single-Domain Antibodies
• 2) By Heavy-Chain Antibodies: Camelid Heavy-Chain Antibodies; Shark Heavy-Chain Antibodies; Engineered Heavy-Chain Antibodies; Chimeric Heavy-Chain Antibodies
• 3) By Recombinant Nano Antibodies: Bacterial Expression Nano Antibodies; Yeast Expression Nano Antibodies; Mammalian Expression Nano Antibodies; Cell-Free Expression Nano Antibodies
• 4) By Conjugated Nano Antibodies: Drug-Conjugated Nano Antibodies; Fluorescent-Conjugated Nano Antibodies; Enzyme-Conjugated Nano Antibodies; Radiolabeled Nano Antibodies
• 5) By Bispecific And Multispecific Nano Antibodies: Dual-Target Nano Antibodies; Tri-Specific Nano Antibodies; Tetravalent Nano Antibodies; Multifunctional Nano Antibodies
• Companies Mentioned: Sanofi S.A.; AstraZeneca plc; Bio-Rad Laboratories Inc.; Bio-Techne Corporation; Innovent Biologics Inc.; GenScript Biotech Corporation; Biocytogen Pharmaceuticals Co. Ltd.; Beroni Group Limited.; Cusabio Technology LLC; Harbour BioMed Co. Ltd.; MoonLake Immunotherapeutics Co. Ltd.; Alphamab Oncology Co. Ltd.; Santa Cruz Biotechnology Inc.; Rockland Immunochemicals Inc.; Creative Biolabs Inc.; Promab Biotechnologies Inc.; ExeVir Bio N.V.; Isogenica Ltd.; Allele Biotechnology And Pharmaceuticals Inc.; Gulliver Biomed Inc.; Capralogics Inc.
• Countries:

Table of Contents

1. Executive Summary

2. Nano Antibodies Market Characteristics

3. Nano Antibodies Market Trends And Strategies

4. Nano Antibodies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nano Antibodies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Nano Antibodies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Nano Antibodies Market Growth Rate Analysis
• 5.4. Global Nano Antibodies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Nano Antibodies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Nano Antibodies Total Addressable Market (TAM)

6. Nano Antibodies Market Segmentation

• 6.1. Global Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Domain Antibodies
• Heavy-Chain Antibodies
• Recombinant Nano Antibodies
• Conjugated Nano Antibodies
• Bispecific And Multispecific Nano Antibodies
• 6.2. Global Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phage Display Technology
• Recombinant Deoxyribonucleic Acid (DNA) Technology
• Molecular Cloning
• 6.3. Global Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Animal-Derived
• Recombinant
• Plant-Derived
• 6.4. Global Nano Antibodies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Detection In Vitro
• Non-Invasive Diagnosis In Vivo
• Tumor Targeted Therapy
• Nervous System Disease
• Circulatory Disease
• Infectious Disease
• Other Applications
• 6.5. Global Nano Antibodies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Firms
• Academic And Research Institutions
• Hospitals And Diagnostic Laboratories
• 6.6. Global Nano Antibodies Market, Sub-Segmentation Of Single-Domain Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Human Single-Domain Antibodies
• Camelid Single-Domain Antibodies
• Synthetic Single-Domain Antibodies
• Shark-Derived Single-Domain Antibodies
• 6.7. Global Nano Antibodies Market, Sub-Segmentation Of Heavy-Chain Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Camelid Heavy-Chain Antibodies
• Shark Heavy-Chain Antibodies
• Engineered Heavy-Chain Antibodies
• Chimeric Heavy-Chain Antibodies
• 6.8. Global Nano Antibodies Market, Sub-Segmentation Of Recombinant Nano Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Expression Nano Antibodies
• Yeast Expression Nano Antibodies
• Mammalian Expression Nano Antibodies
• Cell-Free Expression Nano Antibodies
• 6.9. Global Nano Antibodies Market, Sub-Segmentation Of Conjugated Nano Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Conjugated Nano Antibodies
• Fluorescent-Conjugated Nano Antibodies
• Enzyme-Conjugated Nano Antibodies
• Radiolabeled Nano Antibodies
• 6.10. Global Nano Antibodies Market, Sub-Segmentation Of Bispecific And Multispecific Nano Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dual-Target Nano Antibodies
• Tri-Specific Nano Antibodies
• Tetravalent Nano Antibodies
• Multifunctional Nano Antibodies

7. Nano Antibodies Market Regional And Country Analysis

• 7.1. Global Nano Antibodies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Nano Antibodies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nano Antibodies Market

• 8.1. Asia-Pacific Nano Antibodies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nano Antibodies Market

• 9.1. China Nano Antibodies Market Overview
• 9.2. China Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nano Antibodies Market

• 10.1. India Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nano Antibodies Market

• 11.1. Japan Nano Antibodies Market Overview
• 11.2. Japan Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nano Antibodies Market

• 12.1. Australia Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nano Antibodies Market

• 13.1. Indonesia Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nano Antibodies Market

• 14.1. South Korea Nano Antibodies Market Overview
• 14.2. South Korea Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nano Antibodies Market

• 15.1. Western Europe Nano Antibodies Market Overview
• 15.2. Western Europe Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nano Antibodies Market

• 16.1. UK Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nano Antibodies Market

• 17.1. Germany Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nano Antibodies Market

• 18.1. France Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nano Antibodies Market

• 19.1. Italy Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nano Antibodies Market

• 20.1. Spain Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nano Antibodies Market

• 21.1. Eastern Europe Nano Antibodies Market Overview
• 21.2. Eastern Europe Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nano Antibodies Market

• 22.1. Russia Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nano Antibodies Market

• 23.1. North America Nano Antibodies Market Overview
• 23.2. North America Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nano Antibodies Market

• 24.1. USA Nano Antibodies Market Overview
• 24.2. USA Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nano Antibodies Market

• 25.1. Canada Nano Antibodies Market Overview
• 25.2. Canada Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nano Antibodies Market

• 26.1. South America Nano Antibodies Market Overview
• 26.2. South America Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nano Antibodies Market

• 27.1. Brazil Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nano Antibodies Market

• 28.1. Middle East Nano Antibodies Market Overview
• 28.2. Middle East Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nano Antibodies Market

• 29.1. Africa Nano Antibodies Market Overview
• 29.2. Africa Nano Antibodies Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Nano Antibodies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Nano Antibodies Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nano Antibodies Market Competitive Landscape And Company Profiles

• 30.1. Nano Antibodies Market Competitive Landscape
• 30.2. Nano Antibodies Market Company Profiles
  • 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Innovent Biologics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Nano Antibodies Market Other Major And Innovative Companies

• 31.1. GenScript Biotech Corporation
• 31.2. Biocytogen Pharmaceuticals Co. Ltd.
• 31.3. Beroni Group Limited.
• 31.4. Cusabio Technology LLC
• 31.5. Harbour BioMed Co. Ltd.
• 31.6. MoonLake Immunotherapeutics Co. Ltd.
• 31.7. Alphamab Oncology Co. Ltd.
• 31.8. Santa Cruz Biotechnology Inc.
• 31.9. Rockland Immunochemicals Inc.
• 31.10. Creative Biolabs Inc.
• 31.11. Promab Biotechnologies Inc.
• 31.12. ExeVir Bio N.V.
• 31.13. Isogenica Ltd.
• 31.14. Allele Biotechnology And Pharmaceuticals Inc.
• 31.15. Gulliver Biomed Inc.

32. Global Nano Antibodies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nano Antibodies Market

34. Recent Developments In The Nano Antibodies Market

35. Nano Antibodies Market High Potential Countries, Segments and Strategies

• 35.1 Nano Antibodies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Nano Antibodies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Nano Antibodies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer